Your browser doesn't support javascript.
loading
The NRF2 antagonist ML385 inhibits PI3K-mTOR signaling and growth of lung squamous cell carcinoma cells.
Ji, Lili; Moghal, Nadeem; Zou, Xinru; Fang, Yixuan; Hu, Shuning; Wang, Yuhui; Tsao, Ming Sound.
Afiliação
  • Ji L; Department of Pathology, Key Laboratory of Microenvironment and Translational Cancer Research, Medical School of Nantong University, Nantong, Jiangsu, China.
  • Moghal N; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Zou X; Department of Pathology, Key Laboratory of Microenvironment and Translational Cancer Research, Medical School of Nantong University, Nantong, Jiangsu, China.
  • Fang Y; Department of Pathology, Key Laboratory of Microenvironment and Translational Cancer Research, Medical School of Nantong University, Nantong, Jiangsu, China.
  • Hu S; Department of Pathology, Key Laboratory of Microenvironment and Translational Cancer Research, Medical School of Nantong University, Nantong, Jiangsu, China.
  • Wang Y; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Tsao MS; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Cancer Med ; 12(5): 5688-5702, 2023 03.
Article em En | MEDLINE | ID: mdl-36305267
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China